trending Market Intelligence /marketintelligence/en/news-insights/trending/GsVHx0EyZa7H8A9qpCAQLQ2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us
In This List

Immunotec fiscal Q3 profit falls YOY


So, the data lakehouse is now officially a ‘thing’ – what is it and why should you care?


Industry Top Trends 2021: Oil and Gas


Charter, DIRECTV and Comcast rank as the top 'RSN-friendly' MVPDs

Industry Top Trends 2021: Metals and Mining

Immunotec fiscal Q3 profit falls YOY

Immunotec Inc. said its normalized net income for the fiscal third quarter ended July 31 was C$523,100, a decline of 38.5% from C$850,700 in the prior-year period.

Normalized net income excludes unusual gains or losses on a pre- and after-tax basis.

The normalized profit margin fell to 1.8% from 3.9% in the year-earlier period.

Total revenue climbed 28.6% year over year to C$28.4 million from C$22.1 million, and total operating expenses rose 33.0% on an annual basis to C$27.6 million from C$20.8 million.

Reported net income declined 46.6% on an annual basis to C$629,600, or 1 cents per share, from C$1.2 million, or 2 cents per share.